Trials / Completed
CompletedNCT04089982
Varenicline Light Smoking Pilot
Pilot Study on Varenicline in Light and Intermittent Smokers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to assess varenicline vs. placebo for its effect on decreasing cue reactivity in light and intermittent smokers.
Detailed description
The study will consist of randomization to receive either varenicline or placebo over 6 weeks and include 5 study visits. Participants are offered an optional additional 6 weeks of active varenicline. Cue reactivity will be assessed in both a lab-based setting (viewing series of images and rating cravings) and in a real-world setting (text-based daily interaction).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline | Chantix |
| DRUG | Placebo oral tablet | Placebo |
Timeline
- Start date
- 2019-11-04
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2019-09-16
- Last updated
- 2021-05-11
- Results posted
- 2021-05-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04089982. Inclusion in this directory is not an endorsement.